NICOLAZZO, CHIARA
 Distribuzione geografica
Continente #
AS - Asia 721
SA - Sud America 409
NA - Nord America 55
EU - Europa 38
AF - Africa 12
Totale 1.235
Nazione #
BR - Brasile 319
VN - Vietnam 203
HK - Hong Kong 166
SG - Singapore 153
CN - Cina 93
KR - Corea 75
AR - Argentina 43
US - Stati Uniti d'America 26
MX - Messico 23
EC - Ecuador 18
CO - Colombia 11
IT - Italia 11
ID - Indonesia 9
RU - Federazione Russa 8
CL - Cile 6
BD - Bangladesh 5
PY - Paraguay 5
ZA - Sudafrica 5
MA - Marocco 4
UA - Ucraina 4
UY - Uruguay 4
UZ - Uzbekistan 4
GB - Regno Unito 3
IQ - Iraq 3
DE - Germania 2
DO - Repubblica Dominicana 2
IN - India 2
NL - Olanda 2
PE - Perù 2
PL - Polonia 2
TW - Taiwan 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
ES - Italia 1
FR - Francia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
JP - Giappone 1
KZ - Kazakistan 1
MK - Macedonia 1
SE - Svezia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VE - Venezuela 1
Totale 1.235
Città #
Hong Kong 165
Ho Chi Minh City 77
Seoul 75
Hanoi 37
Singapore 35
São Paulo 25
Beijing 15
Mexico City 15
Dallas 10
Belo Horizonte 9
Haiphong 9
Rio de Janeiro 8
Biên Hòa 7
Guayaquil 7
Thái Bình 7
Concordia 5
Fortaleza 5
Hải Dương 5
Porto Alegre 5
Rome 5
Brasília 4
Curitiba 4
Da Nang 4
Huế 4
New York 4
Osasco 4
Ribeirão Preto 4
Salvador 4
Tashkent 4
Valparaíso de Goiás 4
Belém 3
Buenos Aires 3
Guarulhos 3
Ha Long 3
Ipatinga 3
Jakarta 3
Jundiaí 3
Quito 3
São José dos Campos 3
Thái Nguyên 3
Americana 2
Angra dos Reis 2
Arapongas 2
Araçatuba 2
Barretos 2
Basra 2
Belford Roxo 2
Blumenau 2
Bogotá 2
Bắc Giang 2
Bắc Ninh 2
Camacan 2
Camaçari 2
Campinas 2
Canoas 2
Catanduva 2
Corrientes 2
Criciúma 2
Cruz Alta 2
Dhaka 2
Fernando de la Mora 2
Florianópolis 2
Guaraciaba 2
Itabira 2
Itu 2
João Pessoa 2
Juiz de Fora 2
La Plata 2
Lima 2
Limeira 2
Los Angeles 2
Medellín 2
Milan 2
Montevideo 2
Natal 2
Niterói 2
Nova Iguaçu 2
Novo Hamburgo 2
Ouricuri 2
Paraisópolis 2
Pelotas 2
Petrópolis 2
Porto Ferreira 2
Recife 2
Rio Grande 2
San Bernardo 2
Santa Vitória do Palmar 2
Santo André 2
Santo Domingo 2
Santos 2
Sousa 2
Soweto 2
Suzano 2
São Gonçalo 2
São José 2
Venustiano Carranza 2
Warsaw 2
Yantzaza 2
Đồng Nai Province 2
Abaetetuba 1
Totale 715
Nome #
Evolution of Neo-RAS-WT in Circulating Tumor DNA from First-Line to Subsequent Therapies in Metastatic Colorectal Cancer 44
Is cancer an intelligent species? 41
A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance 39
RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study 39
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors 35
Comparison of two blood-based genotyping tests to investigate the KRAS G12C mutation in patients with non-small-cell lung cancer at failure of first-line treatments 32
Early Detection of Disease Progression in Metastatic Cancers: Could CTCs Improve RECIST Criteria? 31
Blood Extracellular Vesicles Beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients 29
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer 29
Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer 28
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer 27
Circulating methylated dna to monitor the dynamics of ras mutation clearance in plasma from metastatic colorectal cancer patients 27
Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer 26
Signet ring cell carcinoma of the urinary bladder presenting with carcinocythemia and skeletal metastasis: A case report 25
About RAS Mutation Clearance in Plasma ctDNA From RAS-Mutant Colorectal Cancer Patients 24
Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer 24
Detection of circulating tumor cells in patients with laryngeal cancer using ScreenCell: Comparative pre- and post-operative analysis and association with prognosis 24
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer 23
Transient disappearance of RAS mutant clones in plasma: A counterintuitive clinical use of EGFR inhibitors in RAS mutant metastatic colorectal cancer 23
An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer 23
Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff? 23
Circulating Tumor Cells in Right- and Left-Sided Colorectal Cancer 22
Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer 22
The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells 22
Circulating tumor cells isolation: the "post-EpCAM era" 22
Letter to the Editor: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy” 22
Sequential isolation and characterization of single CTCs and large CTC clusters in metastatic colorectal cancer patients 21
An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile 21
Significance of circulating tumor cells in soft tissue sarcoma 21
Editorial: Unveiling the potential of CTCs in drug resistance mechanisms and personalized medicine 20
Circulating tumor cells count and characterization in a male breast cancer patient 20
Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells 20
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study 20
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab 20
EpCAM-expressing circulating tumor cells in colorectal cancer 20
Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial 20
Liquid Biopsy for Predicting Bacillus Calmette-Guérin Unresponsiveness in Non-muscle-invasive Bladder Cancer 19
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature 19
Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma 19
Molecular Characterization of Circulating Tumor Cells to Study Cancer Immunoevasion 19
Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights 18
EpCAMlow Circulating Tumor Cells: Gold in the Waste 18
Why the therapeutic impact of RAS mutation clearance in plasma ctDNA deserves to be further explored in metastatic colorectal cancer 18
In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity 18
Improving the Nuclear-Localized Androgen Receptor Splice Variant 7 Test 17
CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients 17
Circulating tumor cells and "suspicious objects" evaluated through CellSearch® in metastatic renal cell carcinoma 17
The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC) 17
Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer 17
Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal 17
Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: analysis in primary cell cultures of human prostate carcinoma 17
PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system? 17
Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer 16
Coexistence of three EGFR mutations in an NSCLC patient: A brief report 16
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients 16
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients 14
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis 11
The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis 7
Totale 1.293
Categoria #
all - tutte 6.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.466


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025206 0 0 0 0 0 0 14 16 22 114 31 9
2025/20261.087 167 45 300 419 154 2 0 0 0 0 0 0
Totale 1.293